Literature DB >> 11675373

The PU.1 and NF-EM5 binding motifs in the Igkappa 3' enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic Vkappa gene.

M Kodama1, R Hayashi, H Nishizumi, F Nagawa, T Takemori, H Sakano.   

Abstract

Somatic hypermutation is a key mechanism in generating Ig with higher affinities to antigen, a process known as affinity maturation. Using Igkappa transgenes, the 3' enhancer (kappaE3') has been shown to play an important role in introducing hypermutations. In order to identify the cis-acting elements that regulate hypermutagenesis, we have generated transgenic substrates containing mutations/deletions in the kappaE3' region. Here, we report that base substitutions in the kappaE3', either in the PU.1 or in the NF-EM5 binding motif, not only reduce the mutation rate but also disrupt the directed mutagenesis in the intrinsic hotspots of the Igkappa transgene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675373     DOI: 10.1093/intimm/13.11.1415

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.

Authors:  Atsumasa Komori; Zhenming Xu; Xiaoping Wu; Hong Zan; Paolo Casali
Journal:  Mol Immunol       Date:  2006-01-10       Impact factor: 4.407

2.  Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.

Authors:  Diana Ronai; Maria Dolores Iglesias-Ussel; Manxia Fan; Marc J Shulman; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

3.  A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.

Authors:  Ai Kotani; Il-Mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Nasim A Begum; Toshiharu Nakajima; Hirohisa Saito; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

Review 4.  Antibody diversification: mutational mechanisms and oncogenesis.

Authors:  Darina Frieder; Mani Larijani; Ephraim Tang; Jahan-Yar Parsa; Wajiha Basit; Alberto Martin
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

6.  Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.

Authors:  Jean-Marie Buerstedde; Jukka Alinikula; Hiroshi Arakawa; Jessica J McDonald; David G Schatz
Journal:  PLoS Biol       Date:  2014-04-01       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.